1854943-32-0 iruplinalkib

Pwopriyete

Aparans koupe-blan limyè jòn solid
Pwen bouyi: 769.1 ± 7 0. 0 degre
Dansite 1.3 0 ± 0.1 g/cm3
PKA1 0. 12 ± 0.20
 

Aplikasyon:

Iruplinalkib (WX -0593), ke yo rele tou Irulak, se yon roman ALK/ROS1 tirozin kinaz inibitè (TKI) devlope pa QILU famasetik. Se medikaman sa a sitou itilize nan trete avanse ki pa ti kansè nan poumon selil (NSCLC), espesyalman pou ALK pasyan pozitif.

 

Sinonim:

Iruplinalkib

1854943-32-0

Qixinke

Wx -0593

2, 4- Pyrimidinediamine, 5- chloro-n 4- (2- (dimethylphosphinyl) fenil) -n 2- (2- metho xy -4- (9- methyl -3, 9- diazaspiro (5.5) undec -3- yl) fenil)-

5- chloro -4- n-(2- dimethylphosphorylphenyl) -2- n-[2- metoksi {{7} hyl -3, 9- diazaspiro [5.5] undecan -3- yl) fenil] pirimidine -2, 4- Diamine

5- chloro-n 4- (2- (dimethylphosphinyl) fenil) -n 2- (2- metoksi -4- (9-}} methyl -3, 9- diazaspiro (5.5) undec -3- yl) fenil) -2, 4- Pyrimidinediamin

5- chloro -4- n-(2- dimethylphosphorylphenyl) -2- n-(2- metoksi {{7} hyl -3, 9- diazaspiro (5.5) undecan -3- yl) fenil) pyrimidine -2, 4- Diamine

ALK inibitè WX -0593

GTPL11877

FL006

 

Baj popilè: 1854943-32-0 iruplinalkib, Lachin 1854943-32-0 Iruplinalkib manifaktirè, Swèd